144 related articles for article (PubMed ID: 38029851)
21. Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma.
Makita S; Tobinai K
Hematol Oncol Clin North Am; 2017 Apr; 31(2):239-253. PubMed ID: 28340876
[TBL] [Abstract][Full Text] [Related]
22. Development of Extranodal NK/T-cell Lymphoma Nasal Type in Cerebrum Following Epstein-Barr Virus-positive Uveitis.
Imai A; Takase H; Imadome KI; Matsuda G; Ohnishi I; Yamamoto K; Kudo T; Tanaka Y; Maehara T; Miura O; Arai A
Intern Med; 2017; 56(11):1409-1414. PubMed ID: 28566607
[TBL] [Abstract][Full Text] [Related]
23. Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder.
Furuya G; Abe H; Shinozaki-Ushiku A; Yamashita A; Ihara S; Hirata Y; Chiba A; Fujioka Y; Kurokawa M; Koike K; Fukayama M
Pathol Res Pract; 2018 Jul; 214(7):1051-1055. PubMed ID: 29843925
[TBL] [Abstract][Full Text] [Related]
24. Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma.
Wu T; Wang S; Wu J; Lin Z; Sui X; Xu X; Shimizu N; Chen B; Wang X
J Exp Clin Cancer Res; 2015 Feb; 34(1):17. PubMed ID: 25887673
[TBL] [Abstract][Full Text] [Related]
25. Suppression of EBNA1 expression inhibits growth of EBV-positive NK/T cell lymphoma cells.
Ian MX; Lan SZ; Cheng ZF; Dan H; Qiong LH
Cancer Biol Ther; 2008 Oct; 7(10):1602-6. PubMed ID: 18769118
[TBL] [Abstract][Full Text] [Related]
26. EBV in T-/NK-Cell Tumorigenesis.
Kimura H
Adv Exp Med Biol; 2018; 1045():459-475. PubMed ID: 29896680
[TBL] [Abstract][Full Text] [Related]
27. Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America.
Montes-Mojarro IA; Chen BJ; Ramirez-Ibarguen AF; Quezada-Fiallos CM; Pérez-Báez WB; Dueñas D; Casavilca-Zambrano S; Ortiz-Mayor M; Rojas-Bilbao E; García-Rivello H; Metrebian MF; Narbaitz M; Barrionuevo C; Lome-Maldonado C; Bonzheim I; Fend F; Steinhilber J; Quintanilla-Martinez L
Mod Pathol; 2020 May; 33(5):781-791. PubMed ID: 31822801
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
[TBL] [Abstract][Full Text] [Related]
29. Single-Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T-Cell Lymphoma.
Li YQ; Luo CL; Jiang JX; He S; Liu Y; Yan WX; Xia Y; Cui Q; Huang Y; Lim JQ; Huang D; Hussein IN; Gao Y; Lin GW; Ling YH; Ma D; Zhang YT; Chan JY; Wei PP; Wang XX; Cheng CL; Xiong J; Zhao WL; Ong CK; Lim ST; Huang HQ; Peng RJ; Bei JX
Adv Sci (Weinh); 2023 Dec; 10(36):e2303913. PubMed ID: 37949673
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma.
Peng YY; Xiong YY; Zhang LX; Wang J; Zhang HB; Xiao Q; Guo SL
Turk J Haematol; 2021 Jun; 38(2):126-137. PubMed ID: 33535731
[TBL] [Abstract][Full Text] [Related]
31. Clinical features and prognostic model for extranasal NK/T-cell lymphoma.
Jo JC; Yoon DH; Kim S; Lee BJ; Jang YJ; Park CS; Huh J; Lee SW; Ryu JS; Suh C
Eur J Haematol; 2012 Aug; 89(2):103-10. PubMed ID: 22553935
[TBL] [Abstract][Full Text] [Related]
32. NK/T Cell Lymphoma: Updates in Therapy.
Suzuki R
Curr Hematol Malig Rep; 2018 Feb; 13(1):7-12. PubMed ID: 29368155
[TBL] [Abstract][Full Text] [Related]
33. Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL).
Lee J; Cho SG; Chung SM; Ryu MR; Kim SH; Jang HS; Choi BO
Ann Hematol; 2013 Mar; 92(3):333-43. PubMed ID: 23180438
[TBL] [Abstract][Full Text] [Related]
34. Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population.
Chou CC; Tsao CF; Liao CK; You HL; Wang MC; Huang WT
Exp Mol Pathol; 2021 Feb; 118():104577. PubMed ID: 33242451
[TBL] [Abstract][Full Text] [Related]
35. Review on natural killer/T-cell lymphoma.
He X; Gao Y; Li Z; Huang H
Hematol Oncol; 2023 Apr; 41(2):221-229. PubMed ID: 34731509
[TBL] [Abstract][Full Text] [Related]
36. Treatment of refractory/relapsed extranodal NK/T cell lymphoma with decitabine plus anti-PD-1: A case report.
Li LJ; Zhang JY
World J Clin Cases; 2022 Oct; 10(28):10193-10200. PubMed ID: 36246799
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotype.
Ng SB; Ohshima K; Selvarajan V; Huang G; Choo SN; Miyoshi H; Shimizu N; Reghunathan R; Chua HC; Yeoh AE; Quah TC; Koh LP; Tan PL; Chng WJ
Leuk Lymphoma; 2015; 56(8):2408-15. PubMed ID: 25382618
[TBL] [Abstract][Full Text] [Related]
38. Disseminated Mycobacterium marinum Infection With a Destructive Nasal Lesion Mimicking Extranodal NK/T Cell Lymphoma: A Case Report.
Asakura T; Ishii M; Kikuchi T; Kameyama K; Namkoong H; Nakata N; Sugita K; Tasaka S; Shimizu T; Hoshino Y; Okamoto S; Betsuyaku T; Hasegawa N
Medicine (Baltimore); 2016 Mar; 95(11):e3131. PubMed ID: 26986167
[TBL] [Abstract][Full Text] [Related]
39. Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
Yamaguchi M; Suzuki R; Kim SJ; Ko YH; Oguchi M; Asano N; Miyazaki K; Terui Y; Kubota N; Maeda T; Kobayashi Y; Amaki J; Soejima T; Saito B; Shimoda E; Fukuhara N; Tsukamoto N; Shimada K; Choi I; Utsumi T; Ejima Y; Kim WS; Katayama N
Cancer Sci; 2018 Jun; 109(6):2056-2062. PubMed ID: 29601137
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.
Huang Y; de Reyniès A; de Leval L; Ghazi B; Martin-Garcia N; Travert M; Bosq J; Brière J; Petit B; Thomas E; Coppo P; Marafioti T; Emile JF; Delfau-Larue MH; Schmitt C; Gaulard P
Blood; 2010 Feb; 115(6):1226-37. PubMed ID: 19965620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
